Clinical Trials Directory

Trials / Conditions / CDK4/6 Inhibitor

CDK4/6 Inhibitor

6 registered clinical trials studyying CDK4/6 Inhibitor — 5 currently recruiting.

StatusTrialSponsorPhase
Enrolling By InvitationPharmacogenomic and Circulating Biomarkers for CDK4/6 Inhibitors
NCT07100054
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's—
Not Yet RecruitingDevelopment of a New Remote Monitoring Model for Patients With HR+HER2- Breast Cancer in Treatment With CDK4/6
NCT07190651
Fondazione Policlinico Universitario Agostino Gemelli IRCCS—
RecruitingBreast Cancer RElapsed in Patients Treated With Adjuvant CDK4/6 Inhibitors:
NCT07180693
European Institute of Oncology—
Active Not RecruitingEffectiveness and Safety of Palbociclib: Brand vs. Generic in Iraqi Stage IV Breast Cancer Patients
NCT07493291
Al-Mustansiriyah University—
RecruitingSafety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer
NCT06197581
Cancer Institute and Hospital, Chinese Academy of Medical SciencesN/A
RecruitingPredicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advan
NCT06805812
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano—